Abstract
Purpose
Investigation into the characteristics of anesthetic interactions may provide clues to anesthesia mechanisms. Dexmedetomidine, an α2-adrenergic receptor agonist, has become a popular sedative in intensive care, and hydroxyzine, a histamine receptor antagonist, is well known as a tranquilizing premedication for anesthesia. However, no experimental or pharmacological evaluation has been reported concerning their combination with propofol. Thus, we studied their combined effect with a hypnotic dose of propofol in ddY mice.
Methods
Male adult mice were intravenously administered either dexmedetomidine (30 μg/kg) or hydroxyzine (5 mg/kg) with propofol (3.75–10 mg/kg) to induce hypnosis, defined as a loss of the righting reflex (LRR). Other mice were intravenously administered propofol, dexmedetomidine (300 μg/kg), or hydroxyzine (50 mg/kg) alone, and subsequent behavioral changes were observed. The 50% effective dose (ED50) for LRR was calculated, and the duration of LRR was determined.
Results
The hypnotic dose of propofol was 9.95 ± 1.04 mg/kg (ED50 ± SEM) without combination. Dexmedetomidine and hydroxyzine reduced the ED50 of propofol to 5.32 ± 0.57 and 5.63 ± 0.57 mg/kg, respectively. Coadministration of dexmedetomidine significantly extended LRR duration compared with propofol alone, whereas hydroxyzine significantly shortened LRR duration. A maximal dose of dexmedetomidine or hydroxyzine alone did not induce hypnosis.
Conclusions
Dexmedetomidine and hydroxyzine demonstrated no hypnotic action alone; however, their coadministration potentiated the hypnotic activity of propofol. Although reduction in the dose of propofol was similar, only dexmedetomidine prolonged the duration of hypnosis.
Similar content being viewed by others
References
Hendrickx JFA, Eger EI II, Sonner JM, Shafer SL. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth Analg. 2008;107:494–506.
Grass PS. Anesthetic drug interactions: an insight into general anesthesia—its mechanism and dosing strategies. Anesthesiology. 1998;88:5–6.
Rosow C. Anesthetic drug interaction: an overview. J Clin Anesth. 1997;9:S27–32.
Adachi YU, Watanabe K, Higuchi H, Satoh T. A small dose of midazolam decreases the time to achieve hypnosis without delaying emergence during short-term propofol anesthesia. J Clin Anesth. 2001;13:277–80.
Adachi YU, Watanabe K, Higuchi H, Satoh T. Flumazenil reduces the hypnotic dose of propofol in male patients under spinal anesthesia. J Anesth. 2002;16:9–12.
Shafer SL, Hendrickx JFA, Flood P, Sonner J, Eger EI II. Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms. Anesth Analg. 2008;107:507–24.
Eger EI 2nd, Tang M, Liao M, Laster MJ, Slot K, Flood P, Jenkins A, Raines D, Hendrickx JF, Shafer SL, Yasumasa T, Sonner JM. Inhaled anesthetics do not combine to produce synergistic effects regarding minimum alveolar anesthetic concentration in rats. Anesth Analg. 2008;107:479–85.
Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM, Grounds RM. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999;54:1136–42.
Gozal D, Gozal Y. Pediatric sedation/anesthesia outside the operating room. Curr Opin Anaesthesiol. 2008;21:494–8.
Millan MJ, Lejeune F, Gobert A, Brocco M, Auclair A, Bosc C, Rivet JM, Lacoste JM, Cordi A, Dekeyne A. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther. 2000;295:1206–22.
Gengo FM, Dabronzo J, Yurchak A, Love S, Miller JK. The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine. Clin Pharmacol Ther. 1987;42:265–72.
Tornetta FJ. A comparison of droperidol, diazepam, and hydroxyzine hydrochloride as premedication. Anesth Analg. 1977;56:496–500.
Mojdehi E, Mauro AL, Labartino L, Reynolds B. Clinical evaluation of hydroxyzine hydrochloride in pediatric anesthesia and its effect on arousal time. Anesth Analg. 1968;47:685–8.
Zsigmond EK, Patterson RL. Double-blind evaluation of hydroxyzine hydrochloride in obstetric anesthesia. Anesth Analg. 1967;46:275–80.
Adachi YU, Watanabe K, Higuchi H, Satoh T. The determinants of propofol induction of anesthesia dose. Anesth Analg. 2001;92:656–61.
Hans P, Deby-Dupont G, Deby C, Pieron F, Verbesselt R, Franssen C, Lamy M. Increase in antioxidant capacity of plasma during propofol anesthesia. J Neurosurg Anesthesiol. 1997;9:234–6.
Hans P, Coussaert E, Cantraine F, Dewandre PY, Brichant JF, Grevesse M, Lamy M. Effects of target-controlled anesthesia with propofol and sufentanil on the hemodynamic response to Mayfield head holder application. Acta Anaesthesiol Belg. 1998;49:7–11.
Souron V, Delaunay L, Bonner F. Sedation with target-controlled propofol infusion during shoulder surgery under interscalene brachial plexus block in the sitting position: report of a series of 140 patients. Eur J Anaesthesiol. 2005;22:853–7.
Adachi YU, Watanabe K, Higuchi H, Satoh T. High-dose flumazenil potentiates the hypnotic activity of propofol, but not that of thiopental, in ddY mice. Acta Anaesthesiol Scand. 2001;45:848–52.
Salonen M, Reid K, Maze M. Synergistic interaction between alpha 2-adrenergic agonists and benzodiazepines in rats. Anesthesiology. 1992;76:1004–11.
Garfield JM, Bukusoglu C. Propofol and ethanol produce additive hypnotic and anesthetic effects in the mouse. Anesth Analg. 1996;83:156–61.
Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428–36.
Lin J. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev. 2000;4:471–503.
Luo T, Leung LS. Involvement of tuberomamillary histaminergic neurons in isoflurane anesthesia. Anesthesiology. 2011;115:36–43.
Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg. 1987;66:1256–63.
Gupta A, Stierer T, Zuckerman R, Sakima N, Parker SD, Fleisher LA. Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg. 2004;98:632–41.
Hoffman WE, Cunningham F, James MK, Baughman VL, Albrecht RF. Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide. Anesthesiology. 1993;79:107–13.
Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993;79:881–92.
Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, Wiard RP, Feldman PL, Collins H, Waszczak BL, Tilbrook GS. CNS 7056: a novel ultra-short-acting benzodiazepine. Anesthesiology. 2007;107:60–6.
Upton RN, Somogyi AA, Martinez AM, Colvill J, Grant C. Pharmacokinetics and pharmacodynamics of the short-acting sedative CNS 7056 in sheep. Br J Anaesth. 2010;105:798–809.
Ngwenyama NE, Anderson J, Hoernschemeyer DG, Tobias JD. Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescents. Paediatr Anaesth. 2008;18:1190–5.
Peden CJ, Cloote AH, Stratford N, Prys-Roberts C. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia. 2001;56:408–13.
Boussofara M, Bracco D, Ravussin P. Comparison of the effects of clonidine and hydroxyzine on haemodynamic and catecholamine reactions to microlaryngoscopy. Eur J Anaesthesiol. 2001;18:75–8.
Guglielminotti J, Descraques C, Petitmaire S, Almenza L, Grenapin O, Mantz J. Effects of premedication on dose requirements for propofol: comparison of clonidine and hydroxyzine. Br J Anaesth. 1998;80:733–6.
Higuchi H, Adachi Y, Arimura S, Ogata M, Satoh T. Oral clonidine premedication reduces the awakening concentration of propofol. Anesth Analg. 2002;94:609–14.
Richards MJ, Skues MA, Javis AP, Prys-Roberts C. Total i.v. anaesthesia with propofol and alfentanil: dose requirements for propofol and the effect of premedication with clonidine. Br J Anaesth. 1990;65:157–63.
Kelz MB, Sun Y, Chen J, Cheng Meng Q, Moore JT, Veasey SC, Dixon S, Thornton M, Funato H, Yanagisawa M. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci USA. 2008;105:1309–14.
Du C, Tully M, Volkow ND, Schiffer WK, Yu M, Luo Z, Koretsky AP, Benveniste H. Differential effects of anesthetics on cocaine’s pharmacokinetic and pharmacodynamic effects in brain. Eur J Neurosci. 2009;30:1565–75.
Kent AP, Dodson ME, Bower S. The pharmacokinetics and clinical effects of a low dose of alfentanil in elderly patients. Acta Anaesthesiol Belg. 1988;39:25–33.
Mertens MJ, Olofsen E, Burm AG, Bovill JG, Vuyk J. Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics. Anesthesiology. 2004;100:795–805.
Norberg A, Hahn RG, Li H, Olsson J, Prough DS, Børsheim E, Wolf S, Minton RK, Svensén CH. Population volume kinetics predicts retention of 0.9% saline infused in awake and isoflurane-anesthetized volunteers. Anesthesiology. 2007;107:24–32.
Acknowledgment
A part of this study was founded by Grants-in-Aid for Scientific Research from the Japan Society of the Promotion of Science, 22591706.
Conflict of interest
All authors have no conflict of interest for the present investigation.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kimura-Kuroiwa, K., Adachi, Y.U., Obata, Y. et al. Dexmedetomidine and hydroxyzine synergistically potentiate the hypnotic activity of propofol in mice. J Anesth 26, 422–428 (2012). https://doi.org/10.1007/s00540-012-1344-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-012-1344-3